The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide-Reference-Cited by-同舟云学术

The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide

Published:2018-01-15 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Shaim Hila,Estrov Zeev,Harris David,Hernandez Sanabria Mayra,Liu Zhiming,Ruvolo Peter,Thompson Phillip A.,Ferrajoli Alessandra,Daher May,Burger Jan,Muftuoglu Muharrem,Imahashi Nobuhiko,Li Li,Liu Enli,Alsuliman Abdullah Saleh,Basar Rafet,Nassif Kerbauy Lucila,Sobieski Catherine,Gokdemir Elif,Kondo Kayo,Wierda William,Keating Michael,Shpall Elizabeth J.,Rezvani Katayoun

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference56 articles.

1. The biology and treatment of chronic lymphocytic leukemia;Palma;Ann Oncol,2006

2. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma;Tsimberidou;J Clin Oncol,2009

3. Infectious complications in chronic lymphocytic leukemia;Nosari;Mediterr J Hematol Infect Dis,2012

4. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug;Ramsay;J Clin Invest,2008

5. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells;Piper;Clin Exp Immunol,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08

3. Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia;Leukemia Research;2024-08

4. Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway;Cells;2024-06-13

5. BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia;JCI Insight;2024-05-22